Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9201 USD | -0.96% | -17.85% | -31.84% |
Apr. 18 | Top Premarket Decliners | MT |
Apr. 17 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 14.84M | Sales 2025 * | 28.61M | Capitalization | 2.55M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | - | EV / Sales 2024 * | 0.17 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-0.16
x | P/E ratio 2025 * |
-4.65
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.35% |
Latest transcript on INVO Bioscience, Inc.
1 day | -5.69% | ||
1 week | -23.85% | ||
Current month | -7.10% | ||
1 month | -32.19% | ||
3 months | -1.17% | ||
6 months | -45.99% | ||
Current year | -31.19% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Shum
CEO | Chief Executive Officer | 55 | 17-10-10 |
Andrea Goren
DFI | Director of Finance/CFO | 56 | 21-06-13 |
J. Chris Jensen
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trent Davis
BRD | Director/Board Member | 56 | 19-12-15 |
Barbara Ryan
BRD | Director/Board Member | 64 | 20-09-13 |
Corporate Secretary | 55 | 08-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 0.9201 | -0.96% | 28 042 |
24-05-20 | 0.929 | -5.69% | 106,478 |
24-05-17 | 0.985 | -1.50% | 97,640 |
24-05-16 | 1 | -6.54% | 514,009 |
24-05-15 | 1.07 | -4.46% | 155,131 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.19% | 2.55M | |
-6.23% | 180B | |
+2.59% | 112B | |
-2.75% | 68.53B | |
+5.32% | 51.97B | |
+7.61% | 44.08B | |
+5.62% | 42.23B | |
+25.17% | 32.43B | |
+16.72% | 26.39B | |
-2.66% | 24.97B |
- Stock Market
- Equities
- INVO Stock